UPL Limited (NSE: UPL, BSE: 512070) – Intimation of Stake Sale in Bioplanta Nutrição Vegetal

Introduction

On July 29 2026, UPL Limited filed an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). The filing announces the divestment of UPL’s entire stake in Bioplanta Nutrição Vegetal Indústria e Comércio S.A., a joint‑venture associate of the company.

Key Details of the Transaction

Entity and Business

• Bioplanta Nutrição Vegetal Indústria e Comércio S.A. (referred to as “Bioplanta”)
• Engaged in manufacturing, sale, import, export, and tolling of fertilizers, agro‑chemicals (standard or biological), adjuvants, and other agricultural inputs.

Financial Snapshot (FY 2025)

Metric	Amount (USD Mn)
Revenue	7.1
Net‑worth	‑8.2
Profit/(Loss)	‑3.1

Note: As an associate under IND AS, Bioplanta’s figures are not consolidated into UPL’s revenue from operations.

Sale Agreement

• Regulatory approvals: Secured by UPL Brasil on July 29 2026.
• Consideration: Nominal amount of USD 20 (reflecting Bioplanta’s negative net‑worth).
• Expected completion: On or before July 31 2026.

Buyers

• MARINO JOSÉ FRANZ – Brazilian citizen, businessman.
• MIGUEL VAZ RIBEIRO – Brazilian citizen, businessman.

Related‑Party and Compliance Aspects

• Promoter/Group affiliation: Buyers do not belong to UPL’s promoter or group companies.
• Related‑party transaction: The sale does not qualify as a related‑party transaction.
• Scheme of Arrangement / Regulation 37A: Not applicable.
• Slump sale / amalgamation disclosures: Not applicable.

Regulatory Filing

The intimation complies with SEBI Circular No. SEBI/HO/CFD/CFD‑Pod1/P/CIR//2023/123 (13 July 2023) and is submitted as Annexure A to the stock exchanges.

Summary

UPL Limited, through its subsidiary UPL Brasil, is divesting its entire stake in the associate Bioplanta Nutrição Vegetal at a nominal price, with the transaction expected to close by the end of July 2026. The sale is conducted with unrelated third‑party buyers, involves no related‑party concerns, and adheres to all applicable SEBI disclosure requirements.